Researchers have developed and validated a machine learning tool to predict 28-day mortality in ICU patients with sepsis and acute respiratory failure using early clinical data.
Key Details
- 1Machine learning model predicts 28-day mortality risk for ICU patients with sepsis complicated by acute respiratory failure.
- 2Routinely collected clinical data from the first 24 hours of ICU admission were used as input.
- 3Model was trained using MIMIC-IV (v3.1) and externally validated on eICU-CRD (v2.0) databases.
- 4XGBoost outperformed other algorithms in mortality risk discrimination and generalizability.
- 5Model focused on interpretability using SHapley Additive exPlanations (SHAP) to highlight key clinical predictors.
- 6Study published in Journal of Intensive Medicine on January 10, 2026 (DOI: 10.1016/j.jointm.2025.10.010).
Why It Matters
This development demonstrates how interpretable AI can support early clinical risk stratification, guiding resource allocation and treatment in critical care settings. Such models, leveraging large clinical datasets and interpretability tools, are key for integrating AI decision support into real-world healthcare.
Source
EurekAlert
Related News
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.